The unfoldomics decade: an update on intrinsically disordered proteins
Background Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence...
Saved in:
| Published in | BMC genomics Vol. 9; no. Suppl 2; p. S1 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
01.01.2008
BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1471-2164 1471-2164 |
| DOI | 10.1186/1471-2164-9-S2-S1 |
Cover
| Abstract | Background
Our first predictor of protein disorder was published just over a decade ago in the
Proceedings of the IEEE International Conference on Neural Networks
(Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90–95). By now more than twenty other laboratory groups have joined the efforts to improve the prediction of protein disorder. While the various prediction methodologies used for protein intrinsic disorder resemble those methodologies used for secondary structure prediction, the two types of structures are entirely different. For example, the two structural classes have very different dynamic properties, with the irregular secondary structure class being much less mobile than the disorder class. The prediction of secondary structure has been useful. On the other hand, the prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more than 100 year-old views relating protein structure and function. Experimentalists have been providing evidence over many decades that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. In addition, experimentalists are also showing that, for many proteins, their functions depend on the unstructured rather than structured state; such results are in marked contrast to the greater than hundred year old views such as the lock and key hypothesis. Despite extensive data on many important examples, including disease-associated proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our knowledge, current biochemistry books don't present even one acknowledged example of a disorder-dependent function, even though some reports of disorder-dependent functions are more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the results from other bioinformatics studies of intrinsic disorder are demanding attention for these proteins.
Results
Disorder prediction has been important for showing that the relatively few experimentally characterized examples are members of a very large collection of related disordered proteins that are wide-spread over all three domains of life. Many significant biological functions are now known to depend directly on, or are importantly associated with, the unfolded or partially folded state. Here our goal is to review the key discoveries and to weave these discoveries together to support novel approaches for understanding sequence-function relationships.
Conclusion
Intrinsically disordered protein is common across the three domains of life, but especially common among the eukaryotic proteomes. Signaling sequences and sites of posttranslational modifications are frequently, or very likely most often, located within regions of intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different structures with different partners. Also, the flexibility of intrinsic disorder helps different disordered regions to bind to a common binding site on a common partner. Such capacity for binding diversity plays important roles in both protein-protein interaction networks and likely also in gene regulation networks. Such disorder-based signaling is further modulated in multicellular eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much more often than to regions of structure. Associating alternative splicing with disorder rather than structure alleviates theoretical and experimentally observed problems associated with the folding of different length, isomeric amino acid sequences. The combination of disorder and alternative splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways, thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell differentiation and multicellularity. Finally, several recent small molecules of interest as potential drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder of one of the partners. Study of these examples has led to a new approach for drug discovery, and bioinformatics analysis of the human proteome suggests that various disease-associated proteins are very rich in such disorder-based drug discovery targets. |
|---|---|
| AbstractList | Abstract Background Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90–95). By now more than twenty other laboratory groups have joined the efforts to improve the prediction of protein disorder. While the various prediction methodologies used for protein intrinsic disorder resemble those methodologies used for secondary structure prediction, the two types of structures are entirely different. For example, the two structural classes have very different dynamic properties, with the irregular secondary structure class being much less mobile than the disorder class. The prediction of secondary structure has been useful. On the other hand, the prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more than 100 year-old views relating protein structure and function. Experimentalists have been providing evidence over many decades that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. In addition, experimentalists are also showing that, for many proteins, their functions depend on the unstructured rather than structured state; such results are in marked contrast to the greater than hundred year old views such as the lock and key hypothesis. Despite extensive data on many important examples, including disease-associated proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our knowledge, current biochemistry books don't present even one acknowledged example of a disorder-dependent function, even though some reports of disorder-dependent functions are more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the results from other bioinformatics studies of intrinsic disorder are demanding attention for these proteins. Results Disorder prediction has been important for showing that the relatively few experimentally characterized examples are members of a very large collection of related disordered proteins that are wide-spread over all three domains of life. Many significant biological functions are now known to depend directly on, or are importantly associated with, the unfolded or partially folded state. Here our goal is to review the key discoveries and to weave these discoveries together to support novel approaches for understanding sequence-function relationships. Conclusion Intrinsically disordered protein is common across the three domains of life, but especially common among the eukaryotic proteomes. Signaling sequences and sites of posttranslational modifications are frequently, or very likely most often, located within regions of intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different structures with different partners. Also, the flexibility of intrinsic disorder helps different disordered regions to bind to a common binding site on a common partner. Such capacity for binding diversity plays important roles in both protein-protein interaction networks and likely also in gene regulation networks. Such disorder-based signaling is further modulated in multicellular eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much more often than to regions of structure. Associating alternative splicing with disorder rather than structure alleviates theoretical and experimentally observed problems associated with the folding of different length, isomeric amino acid sequences. The combination of disorder and alternative splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways, thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell differentiation and multicellularity. Finally, several recent small molecules of interest as potential drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder of one of the partners. Study of these examples has led to a new approach for drug discovery, and bioinformatics analysis of the human proteome suggests that various disease-associated proteins are very rich in such disorder-based drug discovery targets. Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90-95). By now more than twenty other laboratory groups have joined the efforts to improve the prediction of protein disorder. While the various prediction methodologies used for protein intrinsic disorder resemble those methodologies used for secondary structure prediction, the two types of structures are entirely different. For example, the two structural classes have very different dynamic properties, with the irregular secondary structure class being much less mobile than the disorder class. The prediction of secondary structure has been useful. On the other hand, the prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more than 100 year-old views relating protein structure and function. Experimentalists have been providing evidence over many decades that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. In addition, experimentalists are also showing that, for many proteins, their functions depend on the unstructured rather than structured state; such results are in marked contrast to the greater than hundred year old views such as the lock and key hypothesis. Despite extensive data on many important examples, including disease-associated proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our knowledge, current biochemistry books don't present even one acknowledged example of a disorder-dependent function, even though some reports of disorder-dependent functions are more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the results from other bioinformatics studies of intrinsic disorder are demanding attention for these proteins. Disorder prediction has been important for showing that the relatively few experimentally characterized examples are members of a very large collection of related disordered proteins that are wide-spread over all three domains of life. Many significant biological functions are now known to depend directly on, or are importantly associated with, the unfolded or partially folded state. Here our goal is to review the key discoveries and to weave these discoveries together to support novel approaches for understanding sequence-function relationships. Intrinsically disordered protein is common across the three domains of life, but especially common among the eukaryotic proteomes. Signaling sequences and sites of posttranslational modifications are frequently, or very likely most often, located within regions of intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different structures with different partners. Also, the flexibility of intrinsic disorder helps different disordered regions to bind to a common binding site on a common partner. Such capacity for binding diversity plays important roles in both protein-protein interaction networks and likely also in gene regulation networks. Such disorder-based signaling is further modulated in multicellular eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much more often than to regions of structure. Associating alternative splicing with disorder rather than structure alleviates theoretical and experimentally observed problems associated with the folding of different length, isomeric amino acid sequences. The combination of disorder and alternative splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways, thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell differentiation and multicellularity. Finally, several recent small molecules of interest as potential drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder of one of the partners. Study of these examples has led to a new approach for drug discovery, and bioinformatics analysis of the human proteome suggests that various disease-associated proteins are very rich in such disorder-based drug discovery targets. Background Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90-95). By now more than twenty other laboratory groups have joined the efforts to improve the prediction of protein disorder. While the various prediction methodologies used for protein intrinsic disorder resemble those methodologies used for secondary structure prediction, the two types of structures are entirely different. For example, the two structural classes have very different dynamic properties, with the irregular secondary structure class being much less mobile than the disorder class. The prediction of secondary structure has been useful. On the other hand, the prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more than 100 year-old views relating protein structure and function. Experimentalists have been providing evidence over many decades that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. In addition, experimentalists are also showing that, for many proteins, their functions depend on the unstructured rather than structured state; such results are in marked contrast to the greater than hundred year old views such as the lock and key hypothesis. Despite extensive data on many important examples, including disease-associated proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our knowledge, current biochemistry books don't present even one acknowledged example of a disorder-dependent function, even though some reports of disorder-dependent functions are more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the results from other bioinformatics studies of intrinsic disorder are demanding attention for these proteins. Results Disorder prediction has been important for showing that the relatively few experimentally characterized examples are members of a very large collection of related disordered proteins that are wide-spread over all three domains of life. Many significant biological functions are now known to depend directly on, or are importantly associated with, the unfolded or partially folded state. Here our goal is to review the key discoveries and to weave these discoveries together to support novel approaches for understanding sequence-function relationships. Conclusion Intrinsically disordered protein is common across the three domains of life, but especially common among the eukaryotic proteomes. Signaling sequences and sites of posttranslational modifications are frequently, or very likely most often, located within regions of intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different structures with different partners. Also, the flexibility of intrinsic disorder helps different disordered regions to bind to a common binding site on a common partner. Such capacity for binding diversity plays important roles in both protein-protein interaction networks and likely also in gene regulation networks. Such disorder-based signaling is further modulated in multicellular eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much more often than to regions of structure. Associating alternative splicing with disorder rather than structure alleviates theoretical and experimentally observed problems associated with the folding of different length, isomeric amino acid sequences. The combination of disorder and alternative splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways, thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell differentiation and multicellularity. Finally, several recent small molecules of interest as potential drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder of one of the partners. Study of these examples has led to a new approach for drug discovery, and bioinformatics analysis of the human proteome suggests that various disease-associated proteins are very rich in such disorder-based drug discovery targets. Background Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90–95). By now more than twenty other laboratory groups have joined the efforts to improve the prediction of protein disorder. While the various prediction methodologies used for protein intrinsic disorder resemble those methodologies used for secondary structure prediction, the two types of structures are entirely different. For example, the two structural classes have very different dynamic properties, with the irregular secondary structure class being much less mobile than the disorder class. The prediction of secondary structure has been useful. On the other hand, the prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more than 100 year-old views relating protein structure and function. Experimentalists have been providing evidence over many decades that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. In addition, experimentalists are also showing that, for many proteins, their functions depend on the unstructured rather than structured state; such results are in marked contrast to the greater than hundred year old views such as the lock and key hypothesis. Despite extensive data on many important examples, including disease-associated proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our knowledge, current biochemistry books don't present even one acknowledged example of a disorder-dependent function, even though some reports of disorder-dependent functions are more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the results from other bioinformatics studies of intrinsic disorder are demanding attention for these proteins. Results Disorder prediction has been important for showing that the relatively few experimentally characterized examples are members of a very large collection of related disordered proteins that are wide-spread over all three domains of life. Many significant biological functions are now known to depend directly on, or are importantly associated with, the unfolded or partially folded state. Here our goal is to review the key discoveries and to weave these discoveries together to support novel approaches for understanding sequence-function relationships. Conclusion Intrinsically disordered protein is common across the three domains of life, but especially common among the eukaryotic proteomes. Signaling sequences and sites of posttranslational modifications are frequently, or very likely most often, located within regions of intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different structures with different partners. Also, the flexibility of intrinsic disorder helps different disordered regions to bind to a common binding site on a common partner. Such capacity for binding diversity plays important roles in both protein-protein interaction networks and likely also in gene regulation networks. Such disorder-based signaling is further modulated in multicellular eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much more often than to regions of structure. Associating alternative splicing with disorder rather than structure alleviates theoretical and experimentally observed problems associated with the folding of different length, isomeric amino acid sequences. The combination of disorder and alternative splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways, thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell differentiation and multicellularity. Finally, several recent small molecules of interest as potential drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder of one of the partners. Study of these examples has led to a new approach for drug discovery, and bioinformatics analysis of the human proteome suggests that various disease-associated proteins are very rich in such disorder-based drug discovery targets. Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90-95). By now more than twenty other laboratory groups have joined the efforts to improve the prediction of protein disorder. While the various prediction methodologies used for protein intrinsic disorder resemble those methodologies used for secondary structure prediction, the two types of structures are entirely different. For example, the two structural classes have very different dynamic properties, with the irregular secondary structure class being much less mobile than the disorder class. The prediction of secondary structure has been useful. On the other hand, the prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more than 100 year-old views relating protein structure and function. Experimentalists have been providing evidence over many decades that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. In addition, experimentalists are also showing that, for many proteins, their functions depend on the unstructured rather than structured state; such results are in marked contrast to the greater than hundred year old views such as the lock and key hypothesis. Despite extensive data on many important examples, including disease-associated proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our knowledge, current biochemistry books don't present even one acknowledged example of a disorder-dependent function, even though some reports of disorder-dependent functions are more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the results from other bioinformatics studies of intrinsic disorder are demanding attention for these proteins.BACKGROUNDOur first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero P, Obradovic Z, Kissinger C, Villafranca JE, Dunker AK (1997) Identifying disordered regions in proteins from amino acid sequence. Proceedings of the IEEE International Conference on Neural Networks, 1: 90-95). By now more than twenty other laboratory groups have joined the efforts to improve the prediction of protein disorder. While the various prediction methodologies used for protein intrinsic disorder resemble those methodologies used for secondary structure prediction, the two types of structures are entirely different. For example, the two structural classes have very different dynamic properties, with the irregular secondary structure class being much less mobile than the disorder class. The prediction of secondary structure has been useful. On the other hand, the prediction of intrinsic disorder has been revolutionary, leading to major modifications of the more than 100 year-old views relating protein structure and function. Experimentalists have been providing evidence over many decades that some proteins lack fixed structure or are disordered (or unfolded) under physiological conditions. In addition, experimentalists are also showing that, for many proteins, their functions depend on the unstructured rather than structured state; such results are in marked contrast to the greater than hundred year old views such as the lock and key hypothesis. Despite extensive data on many important examples, including disease-associated proteins, the importance of disorder for protein function has been largely ignored. Indeed, to our knowledge, current biochemistry books don't present even one acknowledged example of a disorder-dependent function, even though some reports of disorder-dependent functions are more than 50 years old. The results from genome-wide predictions of intrinsic disorder and the results from other bioinformatics studies of intrinsic disorder are demanding attention for these proteins.Disorder prediction has been important for showing that the relatively few experimentally characterized examples are members of a very large collection of related disordered proteins that are wide-spread over all three domains of life. Many significant biological functions are now known to depend directly on, or are importantly associated with, the unfolded or partially folded state. Here our goal is to review the key discoveries and to weave these discoveries together to support novel approaches for understanding sequence-function relationships.RESULTSDisorder prediction has been important for showing that the relatively few experimentally characterized examples are members of a very large collection of related disordered proteins that are wide-spread over all three domains of life. Many significant biological functions are now known to depend directly on, or are importantly associated with, the unfolded or partially folded state. Here our goal is to review the key discoveries and to weave these discoveries together to support novel approaches for understanding sequence-function relationships.Intrinsically disordered protein is common across the three domains of life, but especially common among the eukaryotic proteomes. Signaling sequences and sites of posttranslational modifications are frequently, or very likely most often, located within regions of intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different structures with different partners. Also, the flexibility of intrinsic disorder helps different disordered regions to bind to a common binding site on a common partner. Such capacity for binding diversity plays important roles in both protein-protein interaction networks and likely also in gene regulation networks. Such disorder-based signaling is further modulated in multicellular eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much more often than to regions of structure. Associating alternative splicing with disorder rather than structure alleviates theoretical and experimentally observed problems associated with the folding of different length, isomeric amino acid sequences. The combination of disorder and alternative splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways, thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell differentiation and multicellularity. Finally, several recent small molecules of interest as potential drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder of one of the partners. Study of these examples has led to a new approach for drug discovery, and bioinformatics analysis of the human proteome suggests that various disease-associated proteins are very rich in such disorder-based drug discovery targets.CONCLUSIONIntrinsically disordered protein is common across the three domains of life, but especially common among the eukaryotic proteomes. Signaling sequences and sites of posttranslational modifications are frequently, or very likely most often, located within regions of intrinsic disorder. Disorder-to-order transitions are coupled with the adoption of different structures with different partners. Also, the flexibility of intrinsic disorder helps different disordered regions to bind to a common binding site on a common partner. Such capacity for binding diversity plays important roles in both protein-protein interaction networks and likely also in gene regulation networks. Such disorder-based signaling is further modulated in multicellular eukaryotes by alternative splicing, for which such splicing events map to regions of disorder much more often than to regions of structure. Associating alternative splicing with disorder rather than structure alleviates theoretical and experimentally observed problems associated with the folding of different length, isomeric amino acid sequences. The combination of disorder and alternative splicing is proposed to provide a mechanism for easily "trying out" different signaling pathways, thereby providing the mechanism for generating signaling diversity and enabling the evolution of cell differentiation and multicellularity. Finally, several recent small molecules of interest as potential drugs have been shown to act by blocking protein-protein interactions based on intrinsic disorder of one of the partners. Study of these examples has led to a new approach for drug discovery, and bioinformatics analysis of the human proteome suggests that various disease-associated proteins are very rich in such disorder-based drug discovery targets. |
| Author | Chen, Jessica Walton Yang, Jack Y Vacic, Vladimir Obradovic, Zoran Oldfield, Christopher J Romero, Pedro Uversky, Vladimir N Dunker, A Keith Meng, Jingwei |
| Author_xml | – sequence: 1 givenname: A Keith surname: Dunker fullname: Dunker, A Keith email: kedunker@iupui.edu organization: Center for Computational Biology and Bioinformatics, Indiana University Schools of Medicine and Informatics – sequence: 2 givenname: Christopher J surname: Oldfield fullname: Oldfield, Christopher J organization: Center for Computational Biology and Bioinformatics, Indiana University School of Informatics – sequence: 3 givenname: Jingwei surname: Meng fullname: Meng, Jingwei organization: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine – sequence: 4 givenname: Pedro surname: Romero fullname: Romero, Pedro organization: Center for Computational Biology and Bioinformatics, Indiana University School of Informatics – sequence: 5 givenname: Jack Y surname: Yang fullname: Yang, Jack Y organization: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine – sequence: 6 givenname: Jessica Walton surname: Chen fullname: Chen, Jessica Walton organization: Center for Computational Biology and Bioinformatics, Indiana University School of Informatics – sequence: 7 givenname: Vladimir surname: Vacic fullname: Vacic, Vladimir organization: Center for Computational Biology and Bioinformatics, Indiana University School of Informatics – sequence: 8 givenname: Zoran surname: Obradovic fullname: Obradovic, Zoran organization: Center for Information Science and Technology, Temple University – sequence: 9 givenname: Vladimir N surname: Uversky fullname: Uversky, Vladimir N email: vuversky@iupui.edu organization: Center for Computational Biology and Bioinformatics, Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Institute for Intrinsically Disordered Protein Research, Indiana University School of Medicine, Institute for Biological Instrumentation, Russian Academy of Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18831774$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFUctuFDEQtFAQecAHcEFz4jbg9jw8zQ1FBCJF4rB7tzp2T_Bq1l7sGaH8PV52CQih5NRWu6pUVX0uTkIMLMRrkO8Ahv49tBpqBX1bY71S9QqeibOH3clf71NxnvNGStCD6l6IUxiGBrRuz8TV-htXSxjj5OLW21w5tuT4Q0WhWnaOZq5iqHyYkw_ZW5qm-8r5HJPjxK7apThz-Xkpno80ZX51nBdiffVpffmlvvn6-fry401tO41zrZm0c6ikHmTXA1Cr2ZYoKEcC7Vqpbtm6pm-Q-0aBKgNQukYSdoNSzYW4Psi6SBuzS35L6d5E8ubXIqY7Q2n2dmKjgeWI0iIytNTi0BH2TtOoJVgmLFrqoLWEHd3_KMkeBEGafb9m35_Z92fQZGUyFNLbA6kE_75wns3WZ8vTRIHjkk2PxXCPw5NAJZuStsMngYADFgddAb45ApfbLbs_Zo-3LAB9ANgUc048Gutnmn0sxyM__TfVSpnVPhX8w3ysid-cY325YMMdJ7OJSwrl-I-QfgKyz9CP |
| CitedBy_id | crossref_primary_10_4161_idp_25496 crossref_primary_10_1039_C1MB05401E crossref_primary_10_1021_acs_chemrev_8b00038 crossref_primary_10_1089_omi_2022_0137 crossref_primary_10_1016_j_pep_2010_04_020 crossref_primary_10_1093_database_baae109 crossref_primary_10_3389_fphys_2014_00368 crossref_primary_10_1186_s12864_020_06895_2 crossref_primary_10_1016_j_bbapap_2011_05_017 crossref_primary_10_4161_nucl_2_4_16118 crossref_primary_10_1007_s10858_016_0024_2 crossref_primary_10_1016_j_brainresbull_2009_09_015 crossref_primary_10_1002_cbic_201402534 crossref_primary_10_1016_j_bbabio_2015_10_002 crossref_primary_10_1016_j_bbapap_2014_03_010 crossref_primary_10_1371_journal_pone_0023450 crossref_primary_10_1016_j_ijbiomac_2024_139314 crossref_primary_10_3390_ijms25031552 crossref_primary_10_1039_c3mb25517d crossref_primary_10_1080_07060661_2016_1153523 crossref_primary_10_1242_jcs_189928 crossref_primary_10_1002_prot_23077 crossref_primary_10_1039_C1MB05274H crossref_primary_10_3390_polym11060990 crossref_primary_10_1007_s12551_012_0096_5 crossref_primary_10_1016_j_pneurobio_2010_10_006 crossref_primary_10_1021_cr400459c crossref_primary_10_1146_annurev_biochem_78_070907_103305 crossref_primary_10_1063_1_4817215 crossref_primary_10_1073_pnas_1312296111 crossref_primary_10_1155_2010_910524 crossref_primary_10_1002_pro_418 crossref_primary_10_1038_s41467_023_36571_4 crossref_primary_10_1111_j_1469_8137_2010_03502_x crossref_primary_10_3390_ijms160817315 crossref_primary_10_3390_ijms19071899 crossref_primary_10_1016_j_drudis_2013_04_008 crossref_primary_10_1016_j_jmb_2010_11_013 crossref_primary_10_3390_ijms12053205 crossref_primary_10_1111_febs_14182 crossref_primary_10_1007_s00705_022_05575_8 crossref_primary_10_1016_j_jmr_2013_08_008 crossref_primary_10_1074_jbc_M809096200 crossref_primary_10_1016_j_bpj_2010_12_3735 crossref_primary_10_12688_f1000research_20867_1 crossref_primary_10_1126_scisignal_2003345 crossref_primary_10_1016_j_ijbiomac_2022_10_120 crossref_primary_10_1002_pmic_201800307 crossref_primary_10_1073_pnas_1010780107 crossref_primary_10_1186_1471_2105_14_S7_S3 crossref_primary_10_1016_j_pbiomolbio_2010_01_003 crossref_primary_10_1002_cphc_201402661 crossref_primary_10_1016_j_cryobiol_2022_01_004 crossref_primary_10_1101_gr_232645_117 crossref_primary_10_1101_cshperspect_a031724 crossref_primary_10_1038_ncomms3741 crossref_primary_10_1080_07391102_2012_762724 crossref_primary_10_1021_acs_macromol_0c02153 crossref_primary_10_1016_j_chemphys_2013_02_004 crossref_primary_10_1080_07391102_2013_809022 crossref_primary_10_1021_acs_jpcb_3c06170 crossref_primary_10_1186_1471_2164_11_19 crossref_primary_10_1021_bi100222h crossref_primary_10_1021_cr4005692 crossref_primary_10_1039_C1MB05252G crossref_primary_10_1016_j_sbi_2011_02_005 crossref_primary_10_1002_cphc_201300387 crossref_primary_10_3390_ijms151223090 crossref_primary_10_1021_acs_jpcb_2c02268 crossref_primary_10_1038_nchembio_1294 crossref_primary_10_1177_1176935117699408 crossref_primary_10_1016_j_biocel_2011_04_001 crossref_primary_10_1038_s41579_021_00518_7 crossref_primary_10_1016_j_bbapap_2009_08_021 crossref_primary_10_1038_srep05765 crossref_primary_10_1074_jbc_M109_038455 crossref_primary_10_1093_bib_bbab145 crossref_primary_10_1002_biot_201400374 crossref_primary_10_1016_j_jmb_2009_10_075 crossref_primary_10_1089_hgtb_2013_002 crossref_primary_10_1371_journal_pone_0015917 crossref_primary_10_1093_jb_mvad067 crossref_primary_10_1186_1471_2164_11_S4_S11 crossref_primary_10_1371_journal_pone_0039399 crossref_primary_10_1007_s10539_011_9252_8 crossref_primary_10_1039_C8FO01450G crossref_primary_10_1155_2010_568068 crossref_primary_10_1038_s41467_017_02341_2 crossref_primary_10_1371_journal_pone_0011684 crossref_primary_10_1039_C0CS00057D crossref_primary_10_1007_s00894_012_1456_6 crossref_primary_10_1016_j_febslet_2012_04_029 crossref_primary_10_3389_fgene_2018_00158 crossref_primary_10_1371_journal_pone_0006418 crossref_primary_10_1098_rsta_2011_0268 crossref_primary_10_4161_idp_34500 crossref_primary_10_1074_jbc_RA118_001769 crossref_primary_10_1007_s12192_017_0789_6 crossref_primary_10_1002_prot_24239 crossref_primary_10_1007_s11033_010_9962_z crossref_primary_10_1021_acs_chemrev_1c00044 crossref_primary_10_4161_idp_26782 crossref_primary_10_1016_j_pep_2012_08_003 crossref_primary_10_1002_psc_3211 crossref_primary_10_1186_gb_2011_12_12_r120 crossref_primary_10_1371_journal_pone_0023650 crossref_primary_10_1093_database_bat023 crossref_primary_10_1016_j_virol_2013_07_031 crossref_primary_10_1021_cr400525m crossref_primary_10_1371_journal_pcbi_1008546 crossref_primary_10_1586_epr_10_36 crossref_primary_10_1038_nchembio_544 crossref_primary_10_7717_peerj_2 crossref_primary_10_1002_pro_2261 crossref_primary_10_1038_s41598_019_55777_5 crossref_primary_10_1002_prot_24128 crossref_primary_10_1021_cg100363m crossref_primary_10_1186_1471_2164_13_736 crossref_primary_10_3389_fmicb_2017_02396 crossref_primary_10_1007_s10858_013_9761_7 crossref_primary_10_1042_BST20160172 crossref_primary_10_1007_s00018_018_2894_9 crossref_primary_10_1016_j_jprot_2020_103919 crossref_primary_10_3390_ijms24086896 crossref_primary_10_1124_pharmrev_124_001113 crossref_primary_10_1038_s41598_018_37917_5 crossref_primary_10_1093_molbev_msu083 crossref_primary_10_1039_c3mb70329k crossref_primary_10_1074_jbc_M111_333088 crossref_primary_10_1371_journal_pone_0020488 crossref_primary_10_1021_cr4007329 crossref_primary_10_1021_ja203075p crossref_primary_10_1021_bi200365j crossref_primary_10_1021_bi500894q crossref_primary_10_1002_prot_23161 crossref_primary_10_1021_ja200534f crossref_primary_10_1016_j_jmb_2011_09_046 crossref_primary_10_1016_j_abb_2020_108459 crossref_primary_10_1093_bioinformatics_btt411 crossref_primary_10_1016_j_bbagen_2018_07_011 crossref_primary_10_1016_j_brainresrev_2009_05_007 crossref_primary_10_1002_pro_2138 crossref_primary_10_1002_pro_3348 crossref_primary_10_5194_mr_2_511_2021 crossref_primary_10_1007_s10930_009_9201_4 crossref_primary_10_1371_journal_pone_0086013 crossref_primary_10_1021_acs_jproteome_6b00883 crossref_primary_10_1042_BJ20130545 crossref_primary_10_1016_j_jtbi_2015_08_009 crossref_primary_10_1016_j_pbiomolbio_2017_01_005 crossref_primary_10_1016_j_micinf_2010_09_001 crossref_primary_10_1093_bioinformatics_bts327 crossref_primary_10_1038_s41467_022_34417_z crossref_primary_10_1021_acs_biochem_9b00605 crossref_primary_10_1016_j_bpj_2015_06_040 crossref_primary_10_1371_journal_pone_0139731 crossref_primary_10_1039_C7EN00436B crossref_primary_10_1016_j_jmb_2011_10_025 crossref_primary_10_1371_journal_pone_0028877 crossref_primary_10_1039_C1MB05216K crossref_primary_10_1371_journal_pcbi_1003532 crossref_primary_10_1016_j_bpj_2013_02_023 crossref_primary_10_1002_pro_2486 crossref_primary_10_1016_j_bbapap_2011_07_017 crossref_primary_10_1016_j_isci_2023_106229 crossref_primary_10_1093_bioinformatics_btq373 crossref_primary_10_1139_O09_169 crossref_primary_10_1093_nar_gkab408 crossref_primary_10_1093_nar_gkw770 crossref_primary_10_1016_j_bbapap_2010_01_017 crossref_primary_10_1080_07391102_2012_706068 crossref_primary_10_1371_journal_pcbi_1003782 crossref_primary_10_1016_j_jbc_2022_102384 crossref_primary_10_1074_jbc_M111_228981 crossref_primary_10_1021_acs_jctc_4c00942 crossref_primary_10_1038_srep22298 crossref_primary_10_1186_gb_2011_12_7_r65 crossref_primary_10_1021_cg1009303 crossref_primary_10_1021_cr400488d crossref_primary_10_1039_C1MB05235G crossref_primary_10_1007_s41066_019_00202_5 crossref_primary_10_1038_s41587_024_02432_8 crossref_primary_10_1155_2012_292598 crossref_primary_10_1016_j_tibs_2012_11_009 crossref_primary_10_1016_j_str_2010_08_007 crossref_primary_10_1517_17460441_2012_686489 crossref_primary_10_1016_j_bioorg_2021_105305 crossref_primary_10_1038_s41398_021_01258_1 crossref_primary_10_1088_0953_8984_22_3_033103 crossref_primary_10_3390_ijms10041567 crossref_primary_10_1002_pro_370 crossref_primary_10_1002_cphc_200800545 crossref_primary_10_1016_j_molmed_2010_12_003 crossref_primary_10_1007_s11010_014_2050_2 crossref_primary_10_3389_fmolb_2023_1230922 crossref_primary_10_1007_s00705_010_0747_4 crossref_primary_10_1016_j_str_2012_01_021 crossref_primary_10_1074_jbc_M112_346775 crossref_primary_10_1021_acs_biochem_5b01186 crossref_primary_10_1016_j_jmb_2021_166880 crossref_primary_10_1016_j_molcel_2010_12_004 crossref_primary_10_1021_cg901389v crossref_primary_10_1016_j_molcel_2010_08_001 crossref_primary_10_1021_acs_biomac_8b01379 crossref_primary_10_1093_mp_ssq003 crossref_primary_10_4236_jbpc_2011_24051 crossref_primary_10_1128_mBio_00131_10 crossref_primary_10_1128_AEM_00274_12 crossref_primary_10_1371_journal_pone_0035974 crossref_primary_10_1002_jcc_23934 crossref_primary_10_1038_nmeth_4540 crossref_primary_10_1038_s41598_017_07199_4 crossref_primary_10_1016_j_tem_2009_09_001 crossref_primary_10_1002_prot_22839 crossref_primary_10_1016_j_pbiomolbio_2011_01_002 crossref_primary_10_4161_idp_24428 crossref_primary_10_1016_j_bpc_2022_106843 crossref_primary_10_1016_j_biochi_2011_12_018 crossref_primary_10_1074_mcp_M110_001388 crossref_primary_10_1186_gb_2011_12_2_r14 crossref_primary_10_1016_j_febslet_2015_06_004 crossref_primary_10_3390_biom11010054 crossref_primary_10_1021_bi900113v crossref_primary_10_1039_C5MB00640F crossref_primary_10_7717_peerj_1265 crossref_primary_10_3390_biom13060980 crossref_primary_10_1016_j_bbapap_2015_04_031 crossref_primary_10_3390_ijms232214050 crossref_primary_10_1073_pnas_1615536114 crossref_primary_10_1080_21690707_2016_1171278 crossref_primary_10_1586_epr_09_84 crossref_primary_10_1016_j_jmb_2009_03_053 crossref_primary_10_1021_acsbiomaterials_4c00740 crossref_primary_10_1002_pro_3778 crossref_primary_10_1021_cr400514h crossref_primary_10_1038_cr_2009_87 crossref_primary_10_1007_s10858_009_9313_3 crossref_primary_10_1039_b905913j crossref_primary_10_1002_prot_22604 crossref_primary_10_1007_s00249_017_1202_1 crossref_primary_10_1016_j_coviro_2014_02_001 crossref_primary_10_1016_j_febslet_2009_03_070 crossref_primary_10_1128_JVI_06390_11 crossref_primary_10_1016_j_bbapap_2013_11_013 crossref_primary_10_1007_s00726_016_2309_x crossref_primary_10_1021_acs_jafc_7b02477 crossref_primary_10_2222_jsv_63_187 crossref_primary_10_1016_j_sbi_2011_04_001 crossref_primary_10_1186_1471_2229_11_82 crossref_primary_10_3748_wjg_v27_i20_2458 crossref_primary_10_1186_1471_2105_13_111 crossref_primary_10_1128_JVI_01374_12 crossref_primary_10_1093_bioinformatics_btr175 crossref_primary_10_1002_prot_25966 crossref_primary_10_1074_jbc_M111_219857 crossref_primary_10_1371_journal_pone_0036968 crossref_primary_10_1134_S0006297918140043 crossref_primary_10_1042_BJ20111766 crossref_primary_10_1007_s00216_021_03367_8 crossref_primary_10_1007_s00018_009_0014_6 crossref_primary_10_1080_15548627_2016_1140292 crossref_primary_10_1042_BJ20090738 crossref_primary_10_1073_pnas_1409122111 crossref_primary_10_3390_biom8020042 crossref_primary_10_1111_j_1365_2958_2012_08100_x crossref_primary_10_1111_j_1365_2443_2010_01407_x crossref_primary_10_1142_S0218339012400086 crossref_primary_10_1002_pro_2674 crossref_primary_10_3389_fmicb_2016_01419 crossref_primary_10_1007_s42485_021_00075_w crossref_primary_10_3390_ijms25031470 crossref_primary_10_1021_bi2006674 crossref_primary_10_1186_1476_4598_10_101 crossref_primary_10_1039_C7AN01635B crossref_primary_10_1016_j_jsb_2012_05_013 crossref_primary_10_1016_j_ceca_2014_08_011 crossref_primary_10_1016_j_jsb_2019_107428 crossref_primary_10_1128_JB_00293_11 crossref_primary_10_1039_c2fd20064c crossref_primary_10_1002_prot_26261 crossref_primary_10_1016_j_pnmrs_2022_09_001 crossref_primary_10_1039_C8SM02285B crossref_primary_10_1080_07391102_2016_1143877 crossref_primary_10_1016_j_virol_2018_08_002 crossref_primary_10_1016_j_bbrc_2011_05_160 crossref_primary_10_3390_ijms24021444 crossref_primary_10_1039_c003024d crossref_primary_10_3390_ijms26010053 crossref_primary_10_1021_acs_biochem_5b00842 crossref_primary_10_1186_s12859_016_1117_3 crossref_primary_10_1042_BST20190672 crossref_primary_10_1021_acs_chemrev_1c00786 crossref_primary_10_1007_s00018_022_04276_4 crossref_primary_10_1016_j_jmr_2013_12_008 crossref_primary_10_1039_C6MB00657D crossref_primary_10_1038_s41598_023_29742_2 crossref_primary_10_1021_bm900893f crossref_primary_10_1038_srep26234 crossref_primary_10_1080_07391102_2019_1592027 crossref_primary_10_1515_hsz_2015_0303 crossref_primary_10_3389_fmolb_2015_00023 crossref_primary_10_1016_j_febslet_2015_08_014 crossref_primary_10_1007_s12127_016_0201_8 crossref_primary_10_1242_jcs_149922 crossref_primary_10_1016_j_bpj_2010_10_011 crossref_primary_10_1016_j_jmb_2018_11_025 crossref_primary_10_3390_ijms20061322 crossref_primary_10_4161_23723548_2014_970059 crossref_primary_10_1371_journal_pone_0217889 crossref_primary_10_1016_j_bpc_2021_106716 crossref_primary_10_1002_pro_4159 crossref_primary_10_1007_s12551_021_00853_2 crossref_primary_10_1007_s00018_009_0185_1 crossref_primary_10_1038_s41598_022_14382_9 crossref_primary_10_1074_jbc_M116_771097 crossref_primary_10_1007_s00239_019_09921_4 crossref_primary_10_3390_genes2040748 crossref_primary_10_1016_j_pbiomolbio_2009_03_001 crossref_primary_10_1021_la1026416 crossref_primary_10_1371_journal_pone_0092648 crossref_primary_10_1371_journal_pone_0128334 crossref_primary_10_1080_073911012010525030 crossref_primary_10_1111_febs_17405 crossref_primary_10_3390_ijms161023446 crossref_primary_10_1093_jmcb_mjad037 crossref_primary_10_1002_pmic_201800067 crossref_primary_10_1016_j_cytogfr_2015_11_002 crossref_primary_10_1371_journal_pone_0117206 crossref_primary_10_1016_j_ccr_2013_02_018 crossref_primary_10_1007_s10858_015_9932_9 crossref_primary_10_1016_j_eswa_2011_04_160 crossref_primary_10_1186_1471_2105_12_245 crossref_primary_10_1016_j_gpb_2023_03_007 crossref_primary_10_1371_journal_pone_0060724 crossref_primary_10_1002_prot_24303 crossref_primary_10_1002_prot_24424 crossref_primary_10_1073_pnas_1903764116 crossref_primary_10_1142_S0219720012500230 crossref_primary_10_1186_1743_422X_6_59 crossref_primary_10_1021_acs_jcim_3c00145 crossref_primary_10_1039_C1MB05244F crossref_primary_10_2174_0929866526666190226160629 crossref_primary_10_1016_j_virol_2014_12_029 crossref_primary_10_1002_prot_22922 crossref_primary_10_1039_C8RA04760J crossref_primary_10_1007_s00249_009_0510_5 crossref_primary_10_1016_j_cbpb_2010_01_013 crossref_primary_10_1016_j_virol_2010_08_019 crossref_primary_10_1039_C1MB05243H crossref_primary_10_3389_fmicb_2021_739124 crossref_primary_10_1126_scisignal_2003091 crossref_primary_10_1021_acs_chemrev_5b00548 crossref_primary_10_3390_ijms23073862 crossref_primary_10_1371_journal_pone_0073476 crossref_primary_10_3390_ijms12031979 |
| ContentType | Journal Article |
| Copyright | Dunker et al; licensee BioMed Central Ltd. 2008 |
| Copyright_xml | – notice: Dunker et al; licensee BioMed Central Ltd. 2008 |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TM 8FD FR3 P64 RC3 7X8 ADTOC UNPAY DOA |
| DOI | 10.1186/1471-2164-9-S2-S1 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Nucleic Acids Abstracts Technology Research Database Engineering Research Database Biotechnology and BioEngineering Abstracts Genetics Abstracts MEDLINE - Academic Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Genetics Abstracts Engineering Research Database Technology Research Database Nucleic Acids Abstracts Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Genetics Abstracts Genetics Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen Free (Free internet resource, activated by CARLI) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1471-2164 |
| EndPage | S1 |
| ExternalDocumentID | oai_doaj_org_article_71e0f90c99e14a4985a96d7af701cea9 10.1186/1471-2164-9-s2-s1 18831774 10_1186_1471_2164_9_S2_S1 |
| Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NLM NIH HHS grantid: R01 LM007688 – fundername: NIGMS NIH HHS grantid: R01 GM071714 – fundername: NIGMS NIH HHS grantid: GM071714-01A2 – fundername: NLM NIH HHS grantid: R01 LM007688-01A1 – fundername: NLM NIH HHS grantid: R56 LM007688 |
| GroupedDBID | --- 0R~ 23N 2VQ 2WC 2XV 4.4 53G 5VS 6J9 AAFWJ AAHBH AAJSJ AASML ABDBF ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC C1A C6C CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P GROUPED_DOAJ GX1 H13 HYE IAO IGS IHR INH INR IPNFZ ISR ITC KQ8 M48 M~E O5R O5S OK1 OVT P2P PGMZT PIMPY PQQKQ RBZ RIG RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A W2D WOQ WOW XSB 7X7 88E 8AO 8FE 8FH 8FI 8FJ AAYXX ABUWG AEUYN AFKRA BBNVY BHPHI BPHCQ BVXVI CCPQU CITATION FYUFA HCIFZ HMCUK LK8 M1P M7P PHGZM PHGZT PJZUB PPXIY PQGLB PROAC PSQYO PUEGO UKHRP ALIPV CGR CUY CVF ECM EIF NPM 7TM 8FD FR3 P64 RC3 7X8 ADTOC UNPAY |
| ID | FETCH-LOGICAL-c579t-7ea7dd9207805611a47ec11890fa17d402becd3639e632129e6190d30a958223 |
| IEDL.DBID | DOA |
| ISSN | 1471-2164 |
| IngestDate | Fri Oct 03 12:40:41 EDT 2025 Sun Oct 26 04:13:34 EDT 2025 Thu Sep 04 17:24:10 EDT 2025 Thu Sep 04 19:02:00 EDT 2025 Fri Sep 05 10:59:52 EDT 2025 Mon Jul 21 05:47:12 EDT 2025 Thu Apr 24 23:04:23 EDT 2025 Wed Oct 01 03:02:48 EDT 2025 Sat Sep 06 07:28:44 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Suppl 2 |
| Keywords | Alternative Splice Linear Motif Protein Disorder Protein Data Bank Intrinsic Disorder |
| Language | English |
| License | cc-by |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c579t-7ea7dd9207805611a47ec11890fa17d402becd3639e632129e6190d30a958223 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | https://doaj.org/article/71e0f90c99e14a4985a96d7af701cea9 |
| PMID | 18831774 |
| PQID | 19891645 |
| PQPubID | 23462 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_71e0f90c99e14a4985a96d7af701cea9 unpaywall_primary_10_1186_1471_2164_9_s2_s1 proquest_miscellaneous_69619698 proquest_miscellaneous_20340259 proquest_miscellaneous_19891645 pubmed_primary_18831774 crossref_citationtrail_10_1186_1471_2164_9_S2_S1 crossref_primary_10_1186_1471_2164_9_S2_S1 springer_journals_10_1186_1471_2164_9_S2_S1 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2008-01-01 |
| PublicationDateYYYYMMDD | 2008-01-01 |
| PublicationDate_xml | – month: 01 year: 2008 text: 2008-01-01 day: 01 |
| PublicationDecade | 2000 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | BMC genomics |
| PublicationTitleAbbrev | BMC Genomics |
| PublicationTitleAlternate | BMC Genomics |
| PublicationYear | 2008 |
| Publisher | BioMed Central BMC |
| Publisher_xml | – name: BioMed Central – name: BMC |
| SSID | ssj0017825 |
| Score | 2.442277 |
| Snippet | Background
Our first predictor of protein disorder was published just over a decade ago in the
Proceedings of the IEEE International Conference on Neural... Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural Networks (Romero... Background Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on Neural... Abstract Background Our first predictor of protein disorder was published just over a decade ago in the Proceedings of the IEEE International Conference on... |
| SourceID | doaj unpaywall proquest pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | S1 |
| SubjectTerms | Algorithms Alternative Splicing Amino Acid Sequence Animal Genetics and Genomics Binding Sites Biomedical and Life Sciences Computational Biology Drug Design Humans Life Sciences Microarrays Microbial Genetics and Genomics Plant Genetics and Genomics Protein Conformation Protein Folding Proteins - chemistry Proteins - metabolism Proteomics Sequence Analysis, Protein Structure-Activity Relationship |
| SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1di9QwMBwnoj6I366fefDJI5q0aZIRRFRcDuF82Tu4t5BtUhFKd91uudt_7yRt905Y98mnQjtNma_MTGcyQ8gbHwNqKBWDufFMKjNnEGvcqyxkZS5kEKlJ0skPdXwmv58X5wdkHG81ELDdGdrFeVJnq_rd5e_NJ1T4j0nhjXovcINlGfr9DNgsYzMMhm6goYI4yeFEXiUV0BgW6bDRAD4kOXcu8ZeZSt38d7mg19Knd8itrlm6zYWr62sWanqP3B1cS_q5l4X75CA0D8jNftjk5iGZokTQDjGsfTyJ3FIfYm38B-oa2i1j4E8XDf3VrPFLiXX1hvqhN2fwNDV0wCePyOn02-nXYzZMUWBloWHNdHDae8h4nF6ghHBShxKRBl45oT3Gj8hGn6OnElSOhgwv6CT4nDso0HvIH5PDZtGEp4Q6lbvAYa5xSVkEgVtjlRsdpMSYTzkzIXykmS2HDuNx0EVtU6RhlI1ktpHMFuwsszMxIW-3ryz79hr7gL9ERmwBY2fsdGOx-mkHRbNaBF4BLwGCkE6CKRwor12luSiDgwl5PbLRoibF9IhrwqJrbawew68V_4bIeI7kKvasoUDFfkNIiie9hFxhZQy6alpOyNEoMnaU9n0oH22lai-B2sy24tn_INBzcruviYm_mV6Qw_WqCy_R8VrPXyV1-gPHvSQf priority: 102 providerName: Scholars Portal – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEA_SIuqDWK31rLZ58MkSmmTz2bcqHqXQvlwLfQu5TVaEZe_o3iL33zvJ7p4t1AOfFnbzQWYmmZmdyW8Q-hKSQ21LRezcBCKUmRObctwrHnlZMBFZBkm6ulYXt-LyTt4N97jbMdt9DEnmkzpva6NOGRyjhIN1TyyZcTIDl2dXJjQvEOJbfr4JHYDKk0P48slujxRQxul_yrh8EBh9hV50zdKvf_u6fqB7pm_Q68FoxOc9l_fQs9i8Rc_7MpLrd2gKvMYdSEod0h3jFoeYst7PsG9wt0wuPV40-FezgpkyU-o1DgPqZgw4QzXAl310M_1x8_2CDPURSCm1XREdvQ7BcprqEijGvNCxhEVbWnmmA3iGwKBQgA0SVQEqCh6g_kNBvZVgFxTv0U6zaOIHhL0qfKR2rmFIISODQ68qjI5CgDenvJkgOtLMlQN2eCphUbvsQxjlEpldIrOzbsbdjE3Q102XZQ-csa3xt8SITcOEeZ1fLO5_umELOc0irSwtrY1MeGGN9FYF7StNWRm9naDjkY0O9kgKfPgmLrrWpbwwmE3-uwWnBZBLbhlDWZWQhIAUB72E_F2VMWCEaTFBJ6PIuOEgaLct-WQjVVsJ1HLXso__NfYhetmntaQ_RZ_Qzuq-i5_BdlrNj_Je-QO7MQ73 priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZQJwQ8MO6UcfEDT0zu4sTxhbcNUU1ITEjdpPFkObaDKrK0ahqh8us5TtyuTFAJiadK7Ulcn3y2vxMffwehty4E1MpyogrpCOOyICrkuJepT21GmaedSNLnM356wT5d5pexHFA4C1Nc2SBOejW1zWj7AHrVn28I9RP84mjuyn64S35EYXolKbB-osgkJRMIhfZ4DsR8gPYuzr4cf-3OF0WbuK9587omJQ39bWXqBPz_xDq3dkzvoTttPTerH6aqthal8T6q1t3pc1G-j9plMbI_byg9_qf-PkD3I3nFxz3aHqJbvn6EbvflLFeP0Rgwh1tAbOW6prDzIfv-PTY1bufh1QKe1XgKDU_rDhzVCruo_ukd7iQj4Jcn6Hz88fzDKYl1GojNhVoS4Y1wTqVJqI_AKTVMeAv_VSWlocJBhApAcRlwIc8zWCrhA2iIyxKjcuAn2VM0qGe1f46w4ZnxiSoE3JLlnsLkW2ZSeMYgquRGDlGyfkTaRg3zUEqj0l0sI7kO3tHBO1rpSaondIjebS6Z9wIeu4xPwnPfGAbt7e6L2eKbjkNZC-qTUiVWKU-ZYUrmRnEnTCkSar1RQ_RmjRoNYzVswJjaz9pGh_w0aC3_u0WaZOCufMc9uOJB0Qhc8awH5HWvpAQyKNgQHa4RquOE1Ozq8uEGxDsd1KS6oS_-yfoA3e3Ta8Ibq5dosFy0_hVwuGXxOo7NX7Q2PoY priority: 102 providerName: Unpaywall |
| Title | The unfoldomics decade: an update on intrinsically disordered proteins |
| URI | https://link.springer.com/article/10.1186/1471-2164-9-S2-S1 https://www.ncbi.nlm.nih.gov/pubmed/18831774 https://www.proquest.com/docview/19891645 https://www.proquest.com/docview/20340259 https://www.proquest.com/docview/69619698 https://bmcgenomics.biomedcentral.com/counter/pdf/10.1186/1471-2164-9-S2-S1 https://doaj.org/article/71e0f90c99e14a4985a96d7af701cea9 |
| UnpaywallVersion | publishedVersion |
| Volume | 9 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: RBZ dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: KQ8 dateStart: 20000701 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: KQ8 dateStart: 20000101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: DOA dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: ABDBF dateStart: 20000101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: DIK dateStart: 20000101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: M~E dateStart: 20000101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: RPM dateStart: 20000101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1471-2164 dateEnd: 20250331 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: M48 dateStart: 20000701 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: HAS SpringerNature Open Access 2022 customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: AAJSJ dateStart: 20001201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: U2A dateStart: 20001201 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerOpen Free (Free internet resource, activated by CARLI) customDbUrl: eissn: 1471-2164 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017825 issn: 1471-2164 databaseCode: C6C dateStart: 20000112 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBdby1j3ULqPdum6Tg97WhGVZFkffWvDQhm0DNJA9yQUS4aCcUIdM_Lf7yQ7WQZb9tIX2ciyZN2dpDvr9DuEPvtoUJtCEjPVngipp8REH_eSB15kTASWQJJubuX1RHy7z-83Qn1Fn7AOHrgj3LligZaGFsYEJpwwOndGeuVKRVkRXDq6R7VZGVP9_gGse3k6V6QY4WAR9PuZ0PD5Oo8YMuZkzP5YkRJw_9-0zY2d0lfoZVvP3fKnq6qNxWh0gPZ7LRJfdl__Gj0L9Rv0oosruXyLRsB83ILoVD4eOm6wD9EN_gK7GrfzaOPjWY0f6gW0lLhULbHvYTiDxwm7AZ68Q3ejr3fDa9IHTCBFrsyCqOCU94bTGKhAMuaECgV02tDSMeXBVASO-QyUkiAzWLPgAvqAz6gzOSgK2SHaqWd1eI-wk5kL1EwVVCnywGAWLDOtghBg3kmnB4iuaGaLHkw8xrSobDIqtLSRzDaS2Ro75nbMBujL-pV5h6SxrfBVZMS6YATBThkgGrYXDfs_0RigTys2Whg0cSfE1WHWNjY6ikFr-b9LcJoBufItdUgjI7QQkOKok5DfvdIatDIlBuhsJTK2nxmabV0-W0vVVgI13Dbs-CkI9AHtde4v8Y_SCdpZPLbhI-hYi-kpej6Uw9M0qCC9ERrSCYf73cnt98sfvwCwyiEe |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR3LatwwUISEkPRQ2vS1fUWHnBpEJVvWo7dt6bLZPC7eQm5Ca8mlYLxLvKbs33dky9sU0oWcDLYeaN7jGc0gdOaCQ60LQfRCOcKFWhAdctzLxCdFyrhnXZGk6xsx_cFnt9ltvMfdDNnuQ0iyk9QdWyvxmYEYJQlY90STPCE5uDwHIccKuPFgPJ7ls23wAJReFgOYD078RwV1lfofMi_vhUafoKO2XtnNb1tV97TP5Bl6Gs1GPO7x_Bzt-foEHfaNJDcv0ASwjVuglcqFW8YNdj7kvX_BtsbtKjj1eFnjX_UadurQUm2wi3U3vcNdsQb48hLNJ9_n36YkdkggRSb1mkhvpXM6oaEzgWDMcukLOLSmpWXSgW8IKHIpWCFepKCk4AEGgEup1RlYBukrtF8va_8GYStS66leSFiSZ56B2CtTJT3n4M8Jq0aIDjAzRaweHppYVKbzIpQwAcwmgNlokycmZyP0aTtl1ZfO2DX4a0DEdmCoet29WN79NJGJjGSelpoWWnvGLdcqs1o4aUtJWeGtHqHTAY0GuCSEPmztl21jQmYY7Jb9f0RCUwBXtmMNoUWoJQSgeN1TyN9TKQVmmOQjdD6QjImioNl15PMtVe0EUJOYhr191Nqn6Gg6v74yVxc3l-_QcZ_kEv4bvUf767vWfwBLar34GDnnDw5-Eyw |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Za9wwEBYhIW3zENIj7TaXHvrUICLZso6-NZss6RUKm0LehNaSS8Fol9im7L_vyMc2gXShTwZbB5oZaWY8o28QeueiQ61zQfRMOcKFmhEdc9yLxCd5yrhnLUjSt2tx9YN_vs1u-zqn1ZDtPoQkuzsNEaUp1GcLV3RbXIkzBkcqScDSJ5pMEzIF92eLg3KLJQzGYrwKI4D6y_pQ5qPdHiijFrP_MUPzXpB0Bz1twsIuf9uyvKeHJntotzcg8ceO48_Rhg8v0HZXUnL5Ek2A77gBqSldvG9cYedjBvwHbANuFtG9x_OAf4UaZmoZVC6x6xE4vcMtbAN8eYVuJpc34yvS10ogeSZ1TaS30jmd0FijQDBmufQ5LFrTwjLpwEsEZrkU7BEvUlBX8ABTwKXU6gxshHQfbYZ58G8QtiK1nuqZhCF55hkcgEWqpOccPDth1QjRgWYm73HEYzmL0rT-hBImktlEMhttpomZshF6v-qy6EA01jU-j4xYNYz41-2L-d1P028nI5mnhaa51p5xy7XKrBZO2kJSlnurR-hkYKOB_RKDIDb4eVOZmCMGs2X_bpHQFMiVrRlDaBFRhYAUrzsJ-bsqpcAgk3yETgeRMf2hUK1b8ulKqtYSqEpMxd7-19gn6Mn3i4n5-un6ywF61mW7xB9Ih2izvmv8EZhU9ey43TZ_AABoFgk |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1bb9MwFLZQJwQ8MO6UcfEDT0zu4sTxhbcNUU1ITEjdpPFkObaDKrK0ahqh8us5TtyuTFAJiadK7Ulcn3y2vxMffwehty4E1MpyogrpCOOyICrkuJepT21GmaedSNLnM356wT5d5pexHFA4C1Nc2SBOejW1zWj7AHrVn28I9RP84mjuyn64S35EYXolKbB-osgkJRMIhfZ4DsR8gPYuzr4cf-3OF0WbuK9587omJQ39bWXqBPz_xDq3dkzvoTttPTerH6aqthal8T6q1t3pc1G-j9plMbI_byg9_qf-PkD3I3nFxz3aHqJbvn6EbvflLFeP0Rgwh1tAbOW6prDzIfv-PTY1bufh1QKe1XgKDU_rDhzVCruo_ukd7iQj4Jcn6Hz88fzDKYl1GojNhVoS4Y1wTqVJqI_AKTVMeAv_VSWlocJBhApAcRlwIc8zWCrhA2iIyxKjcuAn2VM0qGe1f46w4ZnxiSoE3JLlnsLkW2ZSeMYgquRGDlGyfkTaRg3zUEqj0l0sI7kO3tHBO1rpSaondIjebS6Z9wIeu4xPwnPfGAbt7e6L2eKbjkNZC-qTUiVWKU-ZYUrmRnEnTCkSar1RQ_RmjRoNYzVswJjaz9pGh_w0aC3_u0WaZOCufMc9uOJB0Qhc8awH5HWvpAQyKNgQHa4RquOE1Ozq8uEGxDsd1KS6oS_-yfoA3e3Ta8Ibq5dosFy0_hVwuGXxOo7NX7Q2PoY |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+unfoldomics+decade%3A+an+update+on+intrinsically+disordered+proteins&rft.jtitle=BMC+genomics&rft.au=Vacic+Vladimir&rft.au=Chen+Jessica&rft.au=Yang+Jack+Y&rft.au=Romero+Pedro&rft.date=2008-01-01&rft.pub=BMC&rft.issn=1471-2164&rft.eissn=1471-2164&rft.volume=9&rft.issue=Suppl+2&rft.spage=S1&rft_id=info:doi/10.1186%2F1471-2164-9-S2-S1&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_71e0f90c99e14a4985a96d7af701cea9 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2164&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2164&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2164&client=summon |